Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Top condom maker Karex sees 2022 demand topping pre-pandemic levels

Stock MarketsJan 14, 2022 05:41AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: A staff of of Malaysia's condom manufacturer Karex shows a condom at its factory in Pontian, 320 km (200 miles) southeast of Kuala Lumpur November 7, 2012. REUTERS/Bazuki Muhammad

By Liz Lee

KUALA LUMPUR (Reuters) - The world's top condom maker, Malaysia's Karex Bhd, expects demand to top pre-pandemic levels this year on consumer buying of premium products and restocking by federal health agencies.

Sales to brands such as Durex rose 30% in fiscal 2021 and accounted for 60% of its revenue, up from 49% a year earlier.

"When there was a 40% drop in terms of global consumption, Karex's ... consumer segment has continued to grow," CEO Goh Miah Kiat told Reuters on Friday.

"This year, I expect the demand to recover to pre-pandemic times. Sales value could increase even more as consumers are buying more premium products."

Sales are increasing particularly at the company's consumer business, after the pandemic triggered lockdowns, shutting factories and hampering social activities, Goh told Reuters.

He declined to provide outlook numbers.

In the year ended June 2021, the company's sales grew 6%, versus 4% in the previous year, though it logged its first annual loss since listing in 2013.

For fiscal 2022, analysts expect sales to grow 9%, Refinitiv Eikon data shows.

Goh said demand would be buoyed by restocking by distributors and government departments which have been depleted over the past two years.

"We're starting to see a lot of orders coming in on an emergency basis," Goh said.

The company is also planning to launch new products this year, including a condom made of synthetic material, and is looking to diversify into medical glove manufacturing, Goh said.

It will start out with a target to produce 500 million gloves at its plant in Thailand by March and aims to increase production to a full capacity of 2.5 billion in three years, Goh said.

($1 = 4.1770 ringgit)

Top condom maker Karex sees 2022 demand topping pre-pandemic levels
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email